Corrigendum to “Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)” [Eur J Cancer 2025 Nov 29:232:116138]

European Journal of Cancer 2026 Open access

Read full text

Authors: Alfredo Addeo, Martin Früh

DOI: 10.1016/j.ejca.2026.116224

Cited by: 0

Fields of Study & Subjects

Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations